EWA
ANGO icon

EverSource Wealth Advisors’s AngioDynamics ANGO Stock Holding History

EverSource Wealth Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
1,000
+869
+663% +$9.89K ﹤0.01% 2746
2026
Q1 		$1.49K Sell
131
-158
-55% -$1.71K ﹤0.01% 3739
2025
Q4 		$3.71K Buy
289
+52
+22% +$642 ﹤0.01% 3236
2025
Q3 		$2.65K Sell
237
-134
-36% -$1.29K ﹤0.01% 3418
2025
Q2 		$3.68K Buy
371
+252
+212% +$2.47K ﹤0.01% 3287
2025
Q1 		$1.12K Sell
119
-8
-6% -$84 ﹤0.01% 3190
2024
Q4 		$1.16K Buy
+127
New +$934 ﹤0.01% 2914
2022
Q4 		– Sell
-46
Closed -$1K – 2307
2022
Q3 		$1K Buy
+46
New +$1.01K ﹤0.01% 1772
2022
Q1 		– Sell
-83
Closed -$2K – 1700
2021
Q4 		$2K Buy
+83
New +$2.29K ﹤0.01% 1501

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EverSource Wealth Advisors's ANGO Position: Q2 2026 in Review

EverSource Wealth Advisors increased its AngioDynamics (ANGO) stake by 663% in Q2 2026, buying an estimated $9.89K and bringing the position to 1,000 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

EverSource Wealth Advisors first reported a position in ANGO in Q4 2021 and has held it in 9 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • EverSource Wealth Advisors held 1,000 shares of AngioDynamics worth $13K as of Q2 2026.
  • EverSource Wealth Advisors bought 869 AngioDynamics shares in Q2 2026, an estimated $9.89K.
  • AngioDynamics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2746 holding.
  • EverSource Wealth Advisors first reported a position in AngioDynamics in Q4 2021 and has held it in 9 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.